Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality
worldwide. However, despite the recent developments in the management of CVDs, the …

As major public health concerns associated with a rapidly growing aging population,
neurodegenerative diseases (NDDs) and neurological diseases are important causes of …

Ischemic stroke is a refractory disease that endangers human health and safety owing to
cerebral ischemia. Brain ischemia induces a series of inflammatory reactions. Neutrophils …

As a primary nonpharmacological tool, exercise training is neuroprotective after
experimental ischemic stroke by relieving neuroinflammation. However, the specific …

Stroke is accounted as the second-most mortality and adult disability factor in worldwide,
while causes the bleeding promptly and lifetime consequences. The employed functional …

Ischemic stroke is still one of the leading causes of high mortality and severe disability
worldwide. Therapeutic options for ischemic stroke and subsequent cerebral …

This review explores the diverse applications of gold nanoparticles (AuNPs) in neurological
diseases, with a specific focus on Alzheimer's disease (AD), Parkinson's disease (PD), and …

Background Intravenous administration of fibrinolytic drugs, such as recombinant tissue
plasminogen activator (rtPA) is the standard treatment of acute thrombotic diseases …

Due to the limited clinical treatment options for acute ischemic stroke (AIS), there is still an
urgent requirement for in-depth research on the pathogenesis of AIS and the development of …

Ischemic stroke, caused by the interruption of blood flow to the brain and subsequent
neuronal death, represents one of the main causes of disability in worldwide. Although …